Sector challenges After many years of sustained value creation for shareholders, the pharmaceutical sector has suffered a de-rating since the beginning of 2001. The main factor behind the de-rating is that R&D productivity, which is integral to the growth of the pharmaceutical industry, has ...
Sta- lin tallied the results of the first five-year-plan using figures from the original variant of the plan adopted by the Fifth Congress of Soviets in April–May 1929 and subsequently abandoned due to "deliberately underes- timated indicators," rather than the one adopted under his duress ...